KEENAN GREG (SVP, Chief Medical Officer) received a stock award from AURINIA PHARMACEUTICALS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/3/2026ACC: 0001600620-26-000020
Officer· SVP, Chief Medical Officer
Since Feb 2026
+108.46K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
108.46K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+40.59K
Price / share
—
Trade value
—
% of position
33.3%
2/27/2026
121.93K→162.52K
Total
Net shares
+40.59K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/27/2026 | A · Award | +40.59K | — | — | 33.3% | 121.93K | 162.52K |
| Total | +40.59K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
67.87K shares
Shares
+67.87K
Strike price
13.97
Held after
67.87K
Exercisable
—
2/27/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock67.87K shares | 2/27/2026 | A · Award | +67.87K | 13.97 | — | 67.87K |